Table 1. A correlation analysis between the miR-638 expression level and the clinicopathological characteristics.
| Clinical characteristics | Patients | Low miR-638 expression in tumor(<Median) | High miR-638 expression in tumor(>Median) | P value |
|---|---|---|---|---|
| Age (years) | 68 | |||
| <60 | 21 | 9 | 12 | |
| >=60 | 47 | 25 | 22 | 0.4310 |
| Gender | ||||
| Male | 56 | 25 | 31 | |
| Female | 12 | 9 | 3 | 0.0563 |
| T stage | ||||
| T1-T3 | 26 | 10 | 16 | |
| T4 | 42 | 32 | 30 | 0.6813 |
| Tumor differentiation | ||||
| High-moderate | 42 | 19 | 23 | |
| Poor-undifferentiation | 6326 | 15 | 11 | 0.3182 |
| TNM stage | ||||
| I, II | 30 | 10 | 20 | |
| III, IV | 38 | 24 | 14 | 0.0146* |
| Distant metastasis | ||||
| No | 60 | 31 | 29 | |
| Yes | 8 | 3 | 5 | 0.4516 |
| LN metastasis | ||||
| No | 28 | 10 | 18 | |
| Yes | 40 | 24 | 16 | 0.0487* |